Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Risk assessment of a septic tank variant used for the blackwater treatment.

Created on 24 Sep 2025

Authors

Caroline Kimie Miyazaki, Adriano Luiz Tonetti

Published in

Environmental monitoring and assessment. Volume 197. Issue 10. Pages 1141. Sep 24, 2025. Epub Sep 24, 2025.

Abstract

The reuse of wastewater in agriculture on a single-family scale presents a series of challenges regarding operation, maintenance, and sanitary safety. The present study therefore aimed to assess the potential microbiological risks to which users of a variant of septic tank (biodigester septic tank, BST) are exposed when using this system for treating blackwater (wastewater from toilets) and to propose control measures using the quantitative microbiological risk assessment (QMRA) methodology. This methodology entailed mapping the routes of exposure and calculating the probabilistic infection risk of E. coli. The results indicated that there is a microbiological health risk associated with the BST maintenance and usage. It was proposed that the fresh bovine feces addition for system maintenance should be stopped and that the reuse of the effluent for agricultural purposes should be reused via subsurface irrigation. It is therefore vital to exercise caution and implement a risk management strategy in order to ensure the safe dissemination of this technology in Brazil and Latin America.

PMID:
40987923
Bibliographic data and abstract were imported from PubMed on 24 Sep 2025.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 44
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement